DE102008016218A1 - Hair cleanser with plant extracts - Google Patents

Abstract

The effect of plant extracts in general and of certain plant extracts in particular is enhanced in hair cleansing compositions when present in a cosmetically acceptable vehicle by weight (a) from 0.1 to 35% by weight of at least one surfactant, (b) 0 , 1 to 10 wt .-% of at least one plant extract, and no compounds of formula (I) H- (O-CH 2 CH 2) n -OH (I), in which n stands for integers between 1 and 100,000.

Description

The The present invention relates to hair treatment compositions containing plant extracts contain.

Human Hair is used today in a variety of ways with hair cosmetics Treated preparations. These include cleaning hair with shampoos, care and regeneration with rinses and cures, as well as the bleaching, dyeing and shaping of the Hair with coloring, tinting, waving and styling preparations.

Not lastly by the heavy use of the hair, for example by dyeing or perming as well as by cleaning the hair with shampoos and environmental pollution, the importance of care products with the longest possible effect to. Such care products affect the natural Structure and properties of hair. So afterwards to such treatments, for example, the wet and dry combing hair that optimizes hold and the fullness of the hair his or her hair protected from increased splitting be.

It is therefore common for a long time, the hair of a special To undergo post-treatment. It will, usually in the form of a conditioner, the hair with special active ingredients, for example, quaternary ammonium salts or special ones Polymers, treated. This treatment will vary depending on the formulation the combability, the hold and the fullness of the hair improves and reduces the split rate.

Farther have recently been called so-called combination preparations designed to reduce the overhead of the usual multi-stage process, especially when used directly by consumers.

The available drugs for both separate aftertreatment agents as well as for combined preparations generally act preferentially on the hair surface. Thus, active substances are known which give the hair shine, hold, fullness, give better wet or dry combabilities or prevent the splits. As important as the outer one However, the appearance of the hair is the inner structural cohesion of hair fibers, especially in oxidative and reductive processes as coloring and perms are strongly influenced can.

The However, known active ingredients may not meet all needs cover adequately.

Especially When cleaning hair leads to increased hygiene awareness to an ever more frequent cleaning of the hair. Order here in addition to optimal cleaning and care of hair long-term use To be, the means used must be particularly mild to Hair and scalp. Although mild surfactants are in themselves known to the most diverse groups, but satisfy them not all consumer wishes sufficiently.

So For example, it has been shown that frequent Washing hair will affect the structure of the keratin fibers can, so that the addition of certain substances required is that strengthen the internal structure of the keratin fibers and thus the strength, feel and tensile strength of keratin fibers improve.

It Therefore, there is a need for active ingredients or drug combinations for hair cleansers that have the structure of using them not only do not affect treated fibers, but on the contrary, improve.

Of the Present invention was based on the object, hair cleanser provide advantageous to the hair treated with them Properties in terms of strength, grip and tensile strength and combability give in dry and wet condition and very mild are.

It is known to use plant extracts in cosmetic products, to give the products a specific property profile. It It has now been found that the effect of plant extracts in in particular and by particular plant extracts in particular to increase a special formulation of the products, by formulating the products PEG-free.

• (a) 0,1 bis 35 Gew.-% mindestens eines Tensids,
• (b) 0,1 bis 10 Gew.-% mindestens eines Pflanzenextraktes, dadurch gekennzeichnet, daß sie keine Verbindungen der Formel (I) H-(O-CH₂CH₂)_n-OH (I),in der n für ganze Zahlen zwischen 1 und 100.000 steht, enthalten.

In a first embodiment, the present application relates to hair cleansing compositions containing, in a cosmetically acceptable carrier, based on its weight,

• (a) 0.1 to 35% by weight of at least one surfactant,
• (b) 0.1 to 10% by weight of at least one plant extract, characterized in that they do not contain compounds of the formula (I) H- (O-CH ₂ CH ₂ ) _n -OH (I), in which n stands for integers between 1 and 100,000.

The hair cleansing compositions according to the invention are free of polyethylene glycols of the general formula (I), ie they contain neither ethylene glycol (n = 1) nor products with a degree of polymerisation P _n = 2-4 (diethylene glycol, triethylene glycol and tetraethylene glycol) or polyethylene glycols with higher degrees of polymerization P _n of about 5 to 100,000, which are no longer mol.-uniform produce, but polydisperse.

Surprisingly the omission of compounds of the formula (I) leads to that the plant extracts their effect on the hair clearly unfold better. In particular, the strengthening of the keratinischen Fibers resulting in improved combabilities in dry and especially when wet shows and the fullness and smoothness are improved.

Preferably, the agents according to the invention are not only free of polyethylene glycols but also of polypropylene glycols (PPG). Hair cleansing agents preferred according to the invention are characterized in that they do not contain any compounds of the formula (I)) H- (O-CH (CH ₃ ) CH ₂ ) _n -OH (II), in which n stands for integers between 1 and 100,000.

Such preferred hair cleansing compositions according to the invention are free of polypropylene glycols of the general formula (II), ie they contain neither propylene glycol (n = 1) nor products with a degree of polymerisation P _n = 2-4 (dipropylene glycol, tripropylene glycol and tetrapropylene glycol) or polypropylene glycols with higher degrees of polymerization P _n from about 5 to 100,000, which are no longer molar-uniform producible, but polydisperse.

Also these compounds hinder the unfolding of the action of the plant extracts on the hair, so that by renouncing their use the improved effects can be observed.

It has been found that preferably should be dispensed with the use of ethoxylated compounds. In particular, nonionic surfactants of the alkyl or alkenyl ethoxylate type also reduce the positive effects of the plant extracts and should therefore not be used in the formulations. Further preferred hair cleansing compositions according to the invention are therefore characterized in that they do not contain compounds of the formula (1111) R- (O-CH ₂ CH ₂ ) _n -OH (III), wherein R represents any alkyl or alkenyl radical and n represents integers between 1 and 10,000.

Also ethoxylated anionic surfactants can - albeit in to a lesser extent - the beneficial effects of plant extracts diminish. Here I have in particular alkyl ether sulfates have proved problematic while alkyl ether carboxylates show less effect-reducing effects than the ether sulfates.

Preferred hair cleaners according to the invention therefore contain no compounds of the formula (IV) R- (O-CH ₂ CH ₂ ) _n -OSO ₃ H (IV), where R is any alky or alkenyl radical and n is an integer between 1 and 10,000.

In particularly preferred inventive agents is completely dispensed with the use of compounds having ethoxylated groups. Interestingly, a hydroxyethyl moiety (eg, in certain surfactants) does not affect the action of the plant extracts, while ethylene glycol affects the effect. Preferred hair cleaners according to the invention therefore contain no compound which contains the grouping - (O-CH ₂ CH ₂ ) _n -O- with n = 1-10,000. Particularly preferred hair cleansing compositions according to the invention are characterized in that they contain no compounds which are the Grouping of formula (V) - (O-CH ₂ CH ₂ ) _n - (V), in which n stands for integers between 2 and 100,000.

The agents of the invention contain from 0.1 to 35 Wt .-% of at least one surfactant. As mentioned earlier, excrete ethoxylated nonionic surfactants preferably also anionic Surfactants from the groups of alkyl ether sulfates are preferred not used. As will be explained in detail below, Preferred agents are also free of alkyl sulfates. Especially the use of amphoteric and / or zwitterionic is preferred Surfactants.

Zwitterionic surfactants and emulsifiers are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO ^(-) or -SO ₃ ^(-) group in the molecule. Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl 3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.

Ampholytic surfactants and emulsifiers are understood to mean those surface-active compounds which, apart from a C ₈ -C ₂₄ -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO ₃ H group and are capable of forming internal salts , Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C ₁₂ -C ₁₈ acylsarcosine.

• – N-Alkylglycine,
• – N-Alkylpropionsäuren,
• – N-Alkylaminobuttersäuren,
• – N-Alkyliminodipropionsäuren,
• – N-Hydroxyethyl-N-alkylamidopropylglycine,
• – N-Alkyltaurine,
• – N-Alkylsarcosine,
• – 2-Alkylaminopropionsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe,
• – Alkylaminoessigsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe,
• – N-Kokosalkylaminopropionat,
• – Kokosacylaminoethylaminopropionat
• – C₁₂-C₁₈-Acylsarcosin,
• – N-Alkyl-N,N-dimethylammonium-glycinate, beispielsweise Kokosalkyl-dimethylammo niumglycinat,
• – N-Acyl-aminopropyl-N,N-dimethylammoniumglycinate, beispielsweise Ko kosacylaminopropyl-dimethylammoniumglycinat,
• – 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe
• – Kokosacylaminoethylhydroxyethylcarboxymethylglycinat
• – der unter der INCI-Bezeichnung Cocamidopropyl Betain bekannten Verbindungen,
• – der unter der INCI-Bezeichnung Disodium Cocoamphodiacetate bekannten Verbindungen

enthalten, wobei bevorzugte Mittel das bzw. die amphotere(n) Tensid(e) in Mengen von 0,5 bis 9 Gew.- %, vorzugsweise von 0,75 bis 8 Gew.-% und insbesondere von 1 bis 7,5 Gew.-%, jeweils bezogen auf das gesamte Mittel, enthalten.Particularly preferred hair cleansing compositions according to the invention are characterized in that they contain amphoteric surfactant (s) from the groups of

• - N-alkylglycines,
• N-alkylpropionic acids,
• N-alkylaminobutyric acids,
• N-alkyliminodipropionic acids,
• N-hydroxyethyl-N-alkylamidopropylglycines,
• N-alkyl taurines,
• N-alkyl sarcosines,
• 2-alkylaminopropionic acids each having about 8 to 24 C atoms in the alkyl group,
• Alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group,
• N-cocoalkylaminopropionate,
• - cocoacylaminoethylaminopropionate
• C ₁₂ -C ₁₈ acyl sarcosine,
• N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammoniumglycinate,
• N-acyl-aminopropyl-N, N-dimethylammonium glycinates, for example co-cosacylaminopropyl-dimethylammonium glycinate,
• - 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group
• Cocoacylaminoethylhydroxyethylcarboxymethylglycinate
• The compounds known by the INCI name cocamidopropyl betaine,
• - The known under the INCI name Disodium Cocoamphodiacetate compounds

preferred agents containing the amphoteric surfactant (s) in amounts of 0.5 to 9% by weight, preferably from 0.75 to 8 wt .-% and in particular from 1 to 7.5 wt .-%, each based on the total agent included.

in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenlyrest mit 8 bis 24 Kohlenstoffatomen stehtPreferred hair cleansing compositions according to the invention contain as amphoteric surfactants betaines of the formula (VI)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms

These surfactants are referred to the INCI nomenclature as Amidopropylbetaine, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamidopropylbetaine. According to the invention, particular preference is given to using surfactants of the formula (II) which are a mixture of the following representatives:
H ₃ C- (CH ₂ ) ₇ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₉ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₁ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₃ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₅ -C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) -CH = CH- (CH ₂ ) ₇ C (O) -NH- (CH ₂ ) ₃ N ⁺ (CH ₃ ) ₂ CH ₂ COO ^-

Especially surfactants of the formula (VI) are preferred within narrower ranges used. Here are means according to the invention preferred, which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% surfactant (s) of Formula (VI) included.

enthalten, in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenlyrest mit 8 bis 24 Kohlenstoffatomen steht.In addition to the amphoteric surfactant (s) of the formula (VI) or in its place, the hair cleansing compositions according to the invention may be used with particular preference as amphoteric surfactants betaines of the formula (VII)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms.

These Surfactants are called amphoacetates according to the INCI nomenclature, wherein the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphoactetate.

in der R für einen geradkettigen oder verzweigten, gesättigten oder ein- bzw. mehrfach ungesättigten Alkyl- oder Alkenlyrest mit 8 bis 24 Kohlenstoffatomen und M für ein Kation steht.For reasons of production technology, surfactants of this type always also contain betaines of the formula (VIIa)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms and M is a cation.

These Surfactants are referred to as amphodiacetates according to the INCI nomenclature, where the representatives derived from coconut fatty acids are preferred and are referred to as Cocoamphodiactetate.

According to the invention, particular preference is given to using surfactants of the formula (VII) which are a mixture of the following representatives:
H ₃ C- (CH ₂ ) ₇ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₉ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₁ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₃ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₁₅ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-
H ₃ C- (CH ₂ ) ₇ -CH = CH- (CH ₂ ) ₇ -C (O) -NH- (CH ₂ ) ₂ NH ⁺ (CH ₂ CH ₂ OH) CH ₂ CH ₂ COO ^-

Especially surfactants of the formula (VII) are preferred within narrower ranges of amounts used. Here are means according to the invention preferred, which - based on their weight - 0.25 to 8 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.75 to 6.5 wt .-% and in particular 1 to 5.5 wt .-% surfactant (s) of Formula (VII) included.

• – H₃C-(CH₂)₇-
• – H₃C-(CH₂)₉-
• – H₃C-(CH₂)₁₁-
• – H₃C-(CH₂)₁₃-
• – H₃C-(CH₂)₁₅-
• – H₃C-(CH₂)₇-CH=CH-(CH₂)₇-

oder Mischungen aus diesen.In summary, hair cleansers according to the invention are preferred in which the radical R in the formulas (VI) and (VII) is selected from

• H ₃ C- (CH ₂ ) ₇ -
• H ₃ C- (CH ₂ ) ₉ -
• - H ₃ C- (CH ₂ ) ₁₁ -
• H ₃ C- (CH ₂ ) ₁₃ -
• - H ₃ C- (CH ₂ ) ₁₅ -
• H ₃ C- (CH ₂ ) ₇ -CH = CH- (CH ₂ ) ₇ -

or mixtures of these.

Particularly preferred nonionic surfactants are alkyl polyglycosides. Accordingly, hair cleansing compositions according to the invention are preferred which contain alkylpolyglycosides of the general formula RO - (Z) _x as nonionic surfactants, where R is alkyl, Z is sugar and x is the number of sugar units.

alkylpolyglycosides (APG) are nonionic surfactants that are completely derived from renewable Raw materials (sugar components, predominantly glucose, for example from corn starch and fatty alcohol z. B. from coconut oil) are produced. Alkyl polyglycosides are by acid-catalyzed reaction (Fischer reaction) of sugars, in particular glucose (or starch) or of Butylglycosiden accessible with fatty alcohols.

there complex mixtures of alkyl monoglucoside (alkyl-α-D and -β-D-glucopyranoside and small amounts of glucofuranoside), Alkyldiglucosides (-isomaltosides, maltosides, etc.) and alkyl oligoglucosides (-maltotriosides, tetraosides etc.). The average degree of polymerization commercial products whose alkyl radicals are in the range C8-C16, is 1.2-1.5.

• – im wesentlichen aus C₈- und C₁₀-Alkylgruppen,
• – im wesentlichen aus C₁₂- und C₁₄-Alkylgruppen,
• – im wesentlichen aus C₈- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₂- bis C₁₆-Alkylgruppen oder
• – im wesentlichen aus C₁₆ bis C₁₈-Alkylgruppen

besteht.According to the invention, preference is given to using alkylpolyglycosides corresponding to the general formula RO - (Z) _x , where R is alkyl, Z is sugar and x is the number of sugar units. Particular preference is given to those alkylpolyglycosides in which R

• Consisting essentially of C ₈ and C ₁₀ -alkyl groups,
• Essentially of C ₁₂ and C ₁₄ alkyl groups,
• - Essentially from C ₈ - to C ₁₆ alkyl groups or
• - Essentially from C ₁₂ - to C ₁₆ alkyl groups or
• - Substituted from C ₁₆ to C ₁₈ alkyl groups

consists.

When Sugar building block Z can be any mono- or oligosaccharides be used. Usually, sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides used. Such sugars are, for example, glucose, fructose, galactose, Arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, Idose, talose and sucrose. Preferred sugar building blocks are glucose, Fructose, galactose, arabinose and sucrose; Glucose is special prefers. The alkyl polyglycosides which can be used according to the invention contain on average 1.1 to 5 sugar units. alkylpolyglycosides with x values of 1.1 to 2.0 are preferred. Very particularly preferred are alkyl glycosides in which x is 1.1 to 1.8.

additionally to the surfactants mentioned, the inventive Medium also anionic, cationic and possibly also further contain amphoteric or zwitterionic or nonionic surfactants.

• – lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen (Seifen),
• – Acylsarcoside mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acyltauride mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Acylisethionate mit 8 bis 24 C-Atomen in der Acylgruppe,
• – Sulfobernsteinsäuremono- und -dialkylester mit 8 bis 24 C-Atomen in der Alkylgruppe,
• – lineare Alkansulfonate mit 8 bis 24 C-Atomen,
• – lineare Alpha-Olefinsulfonate mit 8 bis 24 C-Atomen,
• – Alpha-Sulfofettsäuremethylester von Fettsäuren mit 8 bis 30 C-Atomen,
• – Alkylsulfate,
• – Gemische oberflächenaktiver Hydroxysulfonate,
• – Sulfonate ungesättigter Fettsäuren mit 8 bis 24 C-Atomen und 1 bis 6 Doppelbindungen,
• – Monoglyceridsulfate,
• – Kondensationsprodukte aus C₈-C₃₀-Fettalkoholen mit Proteinhydrolysaten und/oder Aminosäuren und deren Derivaten, welche dem Fachmann als Eiweissfettsäurekondensate bekannt sind, wie beispielsweise die Lamepon^®-Typen, Gluadin^®-Typen, Hostapon^® KCG oder die Amisoft^®-Typen.

Suitable anionic surfactants are in principle all suitable for use on the human body an ionic surfactants. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, ester, ether and amide groups as well as hydroxyl groups can be contained in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,

• - linear and branched fatty acids with 8 to 30 carbon atoms (soaps),
• Acylsarcosides having 8 to 24 C atoms in the acyl group,
• Acyltaurides having 8 to 24 carbon atoms in the acyl group,
• Acyl isethionates having 8 to 24 C atoms in the acyl group,
• Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group,
• - linear alkanesulfonates having 8 to 24 carbon atoms,
• - linear alpha-olefin sulfonates having 8 to 24 carbon atoms,
• Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms,
• - alkyl sulfates,
• Mixtures of hydroxysulfonates,
• Sulfonates of unsaturated fatty acids having 8 to 24 C atoms and 1 to 6 double bonds,
• - monoglyceride sulphates,
• - condensation products of C ₈ -C ₃₀ fatty alcohols with protein hydrolysates and / or amino acids and their derivatives, which are known to the skilled person as protein fatty acid condensates, such as Lamepon ^® grades, Gluadin ^® grades, Hostapon ^® KCG or Amisoft ^® grades ,

It is preferred according to the invention, to the use abstain from alkyl and / or alkenyl sulfates to pronounced to get mild properties of the funds. Preferred inventive Hair cleansers are characterized in that they contain no alkyl and alkenyl sulfates.

in the With regard to particularly mild formulations is also the use of alkyl or alkenyl ether sulfates according to the invention not prefers. Here are preferred hair cleansers that do not have alkyl and alkenyl ether sulfates.

As a general rule is the use of sulfate surfactants in the invention Means rather contraindicated, so that particularly preferred hair cleanser according to the invention sulfate-free are.

Usable according to the invention are cationic surfactants of the quaternary ammonium type, the esterquats and the amidoamines. Preferred quaternary Ammonium compounds are ammonium halides, especially chlorides and bromides such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of this Surfactants preferably have 10 to 18 carbon atoms, such as. In cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, Distearyldimethylammonium chloride, lauryldimethylammonium chloride, Lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride. Other preferred cationic surfactants are those under the INCI names Quaternium-27 and quaternium-83 known imidazolium compounds.

• – Alkyltrimethylammoniumchloriden mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Dialkyldimethylammoniumchloride mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Trialkylmethylammoniumchloride mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Cetyltrimethylammoniumchlorid und/oder
• – Stearyltrimethylammoniumchlorid und/oder
• – Distearyldimethylammoniumchlorid und/oder
• – Lauryldimethylammoniumchlorid und/oder
• – Lauryldimethylbenzylammoniumchlorid und/oder
• – Tricetylmethylammoniumchlorid
• – Quaternium-27 und/oder
• – Quaternium-83 und/oder
• – N-Methyl-N(2-hydroxyethyl)-N,N-(ditalgacyloxyethyl)ammonium-methosulfat und/oder
• – N-Methyl-N(2-hydroxyethyl)-N,N-(distearoyloxyethyl)ammonium-methosulfat und/oder
• – N,N-Dimethyl-N,N-distearoyloxyethyl-ammoniumchlorid und/oder
• – N,N-Di-(2-hydroxyethyl)-N,N-(fettsäureesterethyl)-ammoniumchlorid.

Particularly preferred hair cleansing according to the invention are characterized in that they contain as cationic care substance - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3, 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) surfactant (s) from the group of quaternary ammonium compounds and / or the esterquats and / or the amidoamines containing preferred cationic (s) Surfactant (s) is / are selected

• - Alkyltrimethylammoniumchloriden having preferably 10 to 18 carbon atoms in the alkyl radical and / or
• - Dialkyldimethylammoniumchloride having preferably 10 to 18 carbon atoms in the alkyl radical and / or
• - Trialkylmethylammoniumchloride preferably having 10 to 18 carbon atoms in the alkyl radical and / or
• Cetyltrimethylammonium chloride and / or
• Stearyltrimethylammonium chloride and / or
• Distearyldimethylammonium chloride and / or
• - Lauryldimethylammonium chloride and / or
• - Lauryldimethylbenzylammoniumchlorid and / or
• - tricetylmethylammonium chloride
• - Quaternium-27 and / or
• - Quaternium-83 and / or
• - N-methyl-N (2-hydroxyethyl) -N, N- (ditalgacyloxyethyl) ammonium methosulfate and / or
• - N-methyl-N (2-hydroxyethyl) -N, N- (distearoyloxyethyl) ammonium methosulfate and / or
• - N, N-dimethyl-N, N-distearoyloxyethyl ammonium chloride and / or
• - N, N-di (2-hydroxyethyl) -N, N- (fatty acid ethyl) ammonium chloride.

additionally to the surfactant (s) contain the inventive Means at least one plant extract. An extract in the sense of present application is a substance or mixture of substances which by Extraction and partial or complete evaporation of the Extraction solution was obtained. One differentiates after the nature dry extracts d. H. evaporated to dryness Extracts, fluid extracts d. H. prepared with solvents Extracts that from a part drug at most 2 Parts of fluid extract are obtained, viscous Extracts or thickness extracts, d. H. Extracts where part of the Solvent is evaporated.

The plant extracts used according to the invention are obtained from plants or plant parts by extraction, preferably with organic solvents, water or mixtures thereof. Preferred organic solvents are ketones (eg acetone), ethers, esters, alcohols or halogenated hydrocarbons. Particularly preferred extractants are water and / or alcohols. Among the alcohols, (C ₁ to C ₆ ) alcohols, such as ethanol and isopropanol, both as the sole extractant and in admixture with water, are preferred.

The Extraction is preferred at a temperature of 25 ° C up to 90 ° C performed.

Usually These extracts are produced by extraction of the whole plant. However, it may also be preferred in individual cases, the Extracts of flowers and / or leaves only to produce the plant.

With regard to the plant extracts which can be used according to the invention, special mention is made of the extracts which are used in Page 44 of the 3rd edition of the guideline for the declaration of ingredients of cosmetic products, published by the German Association of Personal Care and Detergents e. V. (IKW), Frankfurt , starting table are listed.

According to the invention especially the extracts of green tea, oak bark, stinging nettle, Witch hazel, hops, henna, chamomile, burdock root, horsetail, Hawthorn, lime blossom, almond, aloe vera, spruce needle, Horse chestnut, sandalwood, juniper, coconut, Mango, Apricot, Lime, Wheat, Kiwi, Melon, Orange, Grapefruit, Sage, Rosemary, Birch, Mallow, Meadowfoam, Quendel, Yarrow, Thyme, melissa, hominy, coltsfoot, marshmallow, meristem, ginseng and ginger root preferred.

Especially preferred are the extracts of green tea, oak bark, Stinging nettle, witch hazel, hops, chamomile, burdock root, horsetail, Lime blossom, almond, aloe vera, coconut, mango, Apricot, lime, wheat, kiwi, melon, orange, grapefruit, sage, Rosemary, Birch, Meadowfoam, Quendel, Yarrow, Hauhechel, Meristem, ginseng and ginger root.

The Plant extracts can according to the invention both be used in pure as well as in diluted form. If used in diluted form, contain they usually about 2-80 wt .-% of active substance and as a solvent used in their extraction Extracting agent or extractant mixture.

Farther it may be preferred in the inventive Mixtures of several, especially two, different Use plant extracts.

Especially preferred are extracts of Echinacea or Moringa plants, wherein Echinacea extracts are particularly preferred. The genus of the sun hat family (Echinaceae) includes North American perennials, some of which for a long time for the supportive treatment of infections (inside) and wounds (externally) are used. Echinacea extracts are known to stimulate the Immune system and used as antimicrobial and antiviral substance

The plant extracts from plants of the genus Echinacea can from various Sonnenhutgewächsen (Echinacea, synonym: Brauneria NECKER), in particular from Echinacea angustifolia DC, Echinacea paradoxa (NORTON), Echinacea simulata, E. atrorubens, E. tennesiensis, Echinacea strigosa (MCGREGOR), Echinacea laevigata, Echinacea purpurea (L.) Moench and Echinacea pallida (Nutt), as well as from these extracts to be recovered active substances. Especially preferred are extracts of Sonnenhutgewächsen, in particular of Echinacea purpurea (L) MOENCH used.

Prefers extracts of herb (aboveground parts of plants) and / or root of the sun hat family. The extracts Can be used with water, as well as polar or non-polar organic Solvents and mixtures thereof known in the art Be made way. Extracts by extraction with ethanol or water / ethanol mixtures, can be obtained as well as press juice, are preferred.

It Both the extracts in both the original Extractants as well as extracts / pressed juice in water or other organic solvents and / or mixtures thereof, in particular Ethanol and ethanol / water mixtures are used. Prefers extracted or pressed material is used as a solid, the solvent (in particular as possible gently) was withdrawn. But it can also be such extracts / pressed juices are used, from which the solvent partially withdrawn was used, so that a thickened extract / press juice is used. Very particular preference is pressed juices from the fresh Echinacea purpurea herb (Echinacea purpurea moench herba). Especially The extracts and / or pressed juices are in solid form used.

It It has been shown that certain plant extracts have a special positive effect on fullness, grip and combability have keratinic fibers and that these positive effects be reduced by polyethylene glycols and related substances.

• i Granatapfel,
• ii Roibos,
• iii Mandel,
• iv Holunder,

enthalten.Particularly preferred hair cleansing compositions according to the invention are characterized in that they contain at least one extract from the group of extracts of

• i pomegranate,
• ii Roibos,
• almond,
• iv Elderberry,

contain.

Pomegranate extracts are particularly preferred according to the invention, since these the combability, in particular the wet combability, keratinous fibers significantly improve and the fibers more fullness and give volume.

Of the Pomegranate or Grenadine (Punica granatum) is a species of today the family of the Weiderichgewächse (Lythraceae) is attributed. The genus consisting of two species forms alone the subfamily Punicoideae (Horan.) S.A. Graham, Thorne & Reveal. Homeland the pomegranate is located in western to central Asia; Today he is under grown in the Mediterranean area.

extracts of pomegranate are mainly from the fruits, for Part of whole fruits, partly of pure pulp, partly from pre-washed seeds, partly from the shell. Suitable according to the invention are all of these extracts, for cost reasons Extracts from the whole fruit are preferred, as upstream separation and processing steps are eliminated. Also pomegranate pressed pomegranate oil is inventively used as pomegranate extract. The extracts are rich in pomegranate polyphenols such. B. from Punicalagin, ellagitannin or ellagic acid.

One Another extract according to the invention with particular Preference can be used is Roibos extract, also rooibos extract called. Rooibos (Aspalathus linearis) is a species of plant South Africa, to the legumes (Fabaceae) belongs.

extracts Roibos are made from the branches of the plant. The harvest the red-bush branches take place in the growth resting phase of the shrub from summer to early autumn. As with the tea bush The extracts of Roibos from unfermented branches (Here is by careful handling of the harvested red-bush branches a fermentation avoided, the branches are only dried by means of Sieve cleaned and pasteurized with steam) or fermented Branches (here the branches and branches are cut, squeezed and moistened with water, favored by Leave the warm climate in the producer country this then a 8-24-hour fermentation) produced become. Roibos extracts preferred according to the invention are made from unfermented Roibos.

Another extract that can be used with particular preference according to the invention is Man delextrakt. The almond tree (Prunus dulcis, Syn: Prunus amygdalus), belongs to the family Rosaceae. The almond is an oblong-egg-shaped drupe and has a rough, gray, leathery fruit peel. Almond extracts can be prepared from the flowers, the fruit or the stone of the fruit.

One Another extract according to the invention with particular Preference can be used is elderberry extract. The elder (Sambucus) form a genus in the family of the musk plants (Adoxaceae). The genus contains about 20 to 30 worldwide Species, three of which are native to Central Europe. Best known of these three species is the black elder, which is present in today Linguistic usage mostly abbreviated as "elderberry" becomes. There is also the shrubby red Elder and the perennial or dwarf elder. The species grow in temperate to subtropical Climate and higher elevations of tropical mountains.

The Berry-like drupes contain one to five seeds and can be black, blue or red.

elderberry extracts can be from the flowers, the fruits or the seeds of the fruits are produced. Especially preferred are according to the invention extracts from the fruits of the black elder.

The Leave care effects of the compositions of the invention Strengthen themselves further by using Nursing Enhancer become. Preferably, these will come from certain groups per se selected care substances, as these care enhancers formulation-technical and the care effect with the excellent Plant extracts used according to the invention harmonize.

• i. L-Carnitin und/oder seiner Salze;
• ii. Panthenol und/oder Panthothensäure;
• iii. der 2-Furanone und/oder deren Derivate, insbesondere Pantolacton;
• iv. Taurin und/oder seiner Salze;
• v. Niacinamid;
• vi. Ubichinon
• vii. Ectoin;
• viii. Allantoin;

enthalten.According to preferred hair cleansing compositions are characterized in that they additionally at least one care enhancer from the group

• i. L-carnitine and / or its salts;
• ii. Panthenol and / or panthothenic acid;
• iii. the 2-furanones and / or their derivatives, in particular pantolactone;
• iv. Taurine and / or its salts;
• v. niacinamide;
• vi. ubiquinone
• vii. Ectoin;
• viii. allantoin;

contain.

In Hair treatment compositions of this invention Embodiment becomes the surfactant / plant extract combination combined with at least one Nursing Enhancer selected is from L-carnitine and / or its salts, panthenol and / or panthothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, Taurine and / or its salts, niacinamide, ubiquinones, ectoine, Allantoin, extracts of Echinacea. These care enhancers will be described below

L-carnitine (IUPAC-Name (R) - (3-carboxy-2-hydroxypropyl) -N, N, N-trimethylammonium) is a naturally occurring, vitamin-like Substance. It plays an essential role in energy metabolism human, animal and plant cells. L-carnitine can over different ways are gained on an industrial scale. For example, one, the body's biosynthesis imitating, biotechnological process: in large fermentation tanks is the precursor of L-carnitine (γ-butyrobetaine) with the help of Gram-negative bacteria (rhizobia) in L-carnitine implemented.

When Betaine can form L-carnitine addition compounds and double salts. According to the invention preferred L-carnitine derivatives are in particular selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl L-carnitine and especially preferred L-carnitine tartrate. The L-carnitine compounds mentioned are, for example, of the Company Lonza GmbH (Wuppertal, Germany) available.

invention preferred hair cleansers are characterized in that they - based on their weight - 0.001 to 10 wt .-%, preferably 0.005 bis 7.5 wt .-%, particularly preferably 0.01 to 5 wt .-% and in particular Contain 0.05 to 2.5% by weight of L-carnitine or L-carnitine derivatives, preferred L-carnitine derivatives are selected from Acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.

panthenol (IUPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted into pantothenic acid in the body. Pantothenic acid is a vitamin from the group of B vitamins (Vitamin B5).

invention preferred hair cleansers are characterized in that they - based on its weight - 0.01 to 5 wt .-%, preferably 0.05 to 2.5 wt .-%, particularly preferably 0.1 to 1.5 wt .-% and in particular 0.25 to 1% by weight of panthenol ((±) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethyl-butyramide) contain.

in welchen die Reste R¹ bis R¹⁰ unabhängig voneinander stehen für:

• – Wasserstoff, -OH, einen Methyl-, Methoxy-, Aminomethyl- oder Hydroxymethylrest,
• – -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -NR¹²R¹³, wobei R¹² und R¹³ jeweils unabhängig voneinander stehen für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂- C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -CONR¹⁵R¹⁶, wobei R¹⁵ und R¹⁶ jeweils stehen für Wasserstoff, Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxykohlenwasserstoffrest, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyaminokohlenwasserstoffrest,

mit der Maßgabe, daß für den Fall, wenn R⁷ und R⁸ für -OH und gleichzeitig R⁹ oder R¹⁰ für Wasserstoff stehen, die verbleibende Gruppe R⁹ oder R¹⁰ nicht für einen Dihydroxyethylrest steht.Hair cleansers preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II)

in which the radicals R ¹ to R ^{10 are} independently of one another

• Hydrogen, -OH, a methyl, methoxy, aminomethyl or hydroxymethyl radical,
• --C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or Trihydroxykohlenwasserstoffrest,
• --C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -NR ¹² R ¹³ , wherein R ¹² and R ¹³ each independently represent hydrogen, a methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbyl radical,
• - a group -CONR ¹⁵ R ¹⁶ , wherein R ¹⁵ and R ¹⁶ each represent hydrogen, methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• A group -COR ¹⁶ , where R ¹⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or -or- or di-unsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxy hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical,

with the proviso that when R ⁷ and R ^{8 are} -OH and at the same time R ⁹ or R ^{10 is} hydrogen, the remaining group R ⁹ or R ¹⁰ does not represent a dihydroxyethyl radical.

The Compounds of the formulas (Fur-I) and (Fur-II) are used as intermediates in the synthesis of natural products as well as the production of medicines and vitamins used. The preparation of the active ingredients according to the Formulas (Fur-I) and (Fur-II) can be converted, for example, by reaction of primary alcohols with acrylic acids. Furthermore, compounds of the formula (Fur-I) are obtained by reactions starting from hydroxypivaldehyde. Also carry carbonylations of alkynes to substituted 2-furanones of the formula (Fur-I) or (Fur-II). Finally, the connections can of the formula (Fur-I) or of the formula (Fur-II) by intramolecular Esterification of the corresponding hydroxycarboxylic obtained become. For example, the following connections are on one of the above-identified synthetic routes: 2,5-dihydro-5-methoxy-2-furanone, Tetrahydro-5-oxo-2-furancarboxylic acid, dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone, or 3,4-dimethyl-5-pentylidenedihydro-2 (5H) -furanone or 4-hydroxy-2,5-dimethyl-3 (2H) -furanone. The 2-furanones according to the invention include of course all possible stereoisomers as well as their mixtures. By the 2-furanone according to the invention becomes the odor the cosmetic product is not permanently affected, so that a perfuming of the funds done separately got to.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -NR¹²R¹³, wobei R¹² und R¹³ jeweils unabhängig voneinander stehen für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂- C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxyalkylrest, oder einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyaminokohlenwasserstoffrest.

Preferred compounds of the formula (fur-I) and / or of the formula (fur-II) may be compounds in which the substituents R ¹ , R ² and R ⁷ independently of one another represent:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• A C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -NR ¹² R ¹³ , wherein R ¹² and R ¹³ each independently represent hydrogen, a methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -COOR ^14, wherein R ¹⁴ represents hydrogen, a methyl, a C ₂ -C ₄ - saturated or mono- or diunsaturated branched, or linear hydrocarbon group, a C ₂ - C ₄ - or a saturated - or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• A group -COR ¹⁶ , where R ¹⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or -or- or di-unsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxyalkyl radical, or a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.

In a further embodiment of the teaching according to the invention, it has been found that in the case of the compounds of the formula (Fur-I) or of the formula (Fur-II), the radicals R ³ , R ⁴ and R ^{8 are} preferably, independently of one another,

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.

Furthermore, it may be preferred for the radicals R ⁵ , R ⁶ , R ⁹ and R ¹⁰ in the active substance according to the formula (I) and / or formula (II) according to the invention independently of one another to be:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxykohlenwasserstoffrest.

In a particularly preferred embodiment of the teaching according to the invention, a compound of the formula (Fur-I) is used. It may be preferred that in a compound of the formula (fur-I), the radicals R ¹ and R ^{2 are} independently of one another:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COR ¹⁶ , where R ¹⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or -or- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxykohlenwasserstoffrest.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄- gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀- gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- und/oder Polyhydroxykohlenwasserstoffrest.

Furthermore, in this particularly preferred embodiment of the teaching according to the invention, it may be advantageous if in the compounds of the formula (Fur-I) the radicals R ³ and R ⁴ independently of one another represent:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- and / or polyhydroxy hydrocarbon radical.

• – einen -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest.

In this preferred embodiment, it may furthermore be advantageous for the compounds of the formula (Fur I) for the radicals R 5 and R 6 to stand independently for:

• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbon radical.

• – (R)-(–)-4-Hydroxymethyl-ϒ-butyrolacton und/oder
• – D,L-4-Hydroxymethyl-γ-butyrolacton und/oder
• – (S)-(+)-4-Hydroxymethyl-γ-butyrolacton und/oder
• – R-(–)-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – D,L-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – S(+)-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – 4-Hydroxy-2,5-dimethyl-3(2H)-furanon und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure, Na-Salz und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure, K-Salz und/oder
• – 2,5-Dihydro-5-methoxy-2-furanon und/oder
• – Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanon

eingesetzt. In einer ganz besonders bevorzugten Ausführungsform der erfindungsgemäßen Lehre wird als Verbindung entsprechend der Formel (Fur-I) Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanon eingesetzt.In a particularly preferred embodiment of the teaching according to the invention is used as the compound according to the formula (Fur-I)

• - (R) - (-) - 4-hydroxymethyl-Υ-butyrolactone and / or
• - D, L-4-hydroxymethyl-γ-butyrolactone and / or
• - (S) - (+) - 4-hydroxymethyl-γ-butyrolactone and / or
• - R - (-) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• - D, L-2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• - S (+) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• 4-hydroxy-2,5-dimethyl-3 (2H) -furanone and / or
• - Tetrahydro-5-oxo-2-furancarbonsäure and / or
• - Tetrahydro-5-oxo-2-furancarbonsäure, Na salt and / or
• Tetrahydro-5-oxo-2-furancarboxylic acid, K salt and / or
• 2,5-dihydro-5-methoxy-2-furanone and / or
• Dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone

used. In a very particularly preferred embodiment of the teaching according to the invention is used as a compound corresponding to the formula (Fur-I) dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone.

One Another, more preferred care enhancer, the activating Possesses properties, is the taurine. According to the invention preferred Hair cleansers contain - based on their weight - 0.01 to 15% by weight, preferably 0.025 to 12.5% by weight, more preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).

Another preferred group of skin care enhancers in the compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below:
The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.

• – Vitamin B₁ (Thiamin)
• – Vitamin B₂ (Riboflavin)
• – Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. Erfindungsgemäß bevorzugt ist das Nicotinsäureamid, das in den erfindungsgemäß verwendeten Mitteln bevorzugt in Mengen von 0,05 bis 1 Gew.-%, bezogen auf das gesamte Mittel, enthalten ist.
• – Vitamin B₅ (Pantothensäure, Panthenol und Pantolacton). Im Rahmen dieser Gruppe wird bevorzugt das Panthenol und/oder Pantolacton eingesetzt (siehe weiter unten). Erfindungsgemäß einsetzbare Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols sowie kationisch derivatisierte Panthenole. Einzelne Vertreter sind beispielsweise das Panthenoltriacetat, der Panthenolmonoethylether und dessen Monoacetat sowie die in der WO 92/13829 offenbarten kationischen Panthenolderivate. Die genannten Verbindungen des Vitamin B₅-Typs sind in den erfindungsgemäßen Mitteln bevorzugt in Mengen von 0,05–10 Gew.-%, bezogen auf das gesamte Mittel, enthalten. Mengen von 0,1–5 Gew.-% sind besonders bevorzugt.
• – Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal).

The vitamin B group or the vitamin B complex include, among others

• - Vitamin B ₁ (thiamine)
• - Vitamin B ₂ (riboflavin)
• - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
• - Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group (see below). Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenoltriacetat, the Panthenolmonoethylether and its monoacetate as well as in the WO 92/13829 disclosed cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably present in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
• - Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

vitamin C (ascorbic acid). Vitamin C is in the inventive Agents preferably in amounts of 0.1 to 3 wt .-%, based on the entire funds used. The use in the form of palmitic acid ester, the glucoside or phosphates may be preferred. The usage in combination with tocopherols may also be preferred.

vitamin E (tocopherols, especially α-tocopherol). tocopherol and its derivatives, including in particular the esters such as the acetate, nicotinate, phosphate and succinate are in the agents according to the invention preferably in amounts from 0.05 to 1% by weight, based on the total agent.

vitamin F. The term "vitamin F" is commonly used essential fatty acids, especially linoleic acid, Linolenic acid and arachidonic acid, understood.

vitamin H. As vitamin H, the compound becomes (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid but for the meantime the trivial name Biotin has prevailed. Biotin is in the invention Agents preferably in amounts of 0.0001 to 1.0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.

In summary, preference is given to hair cleansing compositions according to the invention which, based on their weight, are 0.1 to 5% by weight, preferably 0.2 to 4% by weight, more preferably 0.25 to 3.5% by weight, more preferably 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or Containing vitamin precursors preferably assigned to groups A, B, C, E, F and H, preferred agents being 2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin 135) and / or pantothenic acid (vitamin B ₃ , vitamin B ₅ ) and / or niacin, niacinamide or nicotinamide (vitamin B ₃ ) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin B ₁ ) and / or riboflavin (Vitamin B ₂ , Vitamin G) and / or biotin (Vitamin B ₇ , Vitamin H) and / or folic acid (Vitamin B ₉ , Vitamin B _c or Vitamin M) and / or Vitamin B ₆ and / or Vitamin B ₁₂ .

enthalten in der
X, Y, Z stehen unabhängig voneinander für -O- oder -NH- oder NR⁴- oder eine chemische Bindung
R¹, R², R³ stehen unabhängig voneinander für ein Wasserstoffatom oder eine gegebenenfalls substituierte Arylgruppe oder eine gegebenenfalls substituierte (C₁-C₆)-Alkylgruppe oder eine Hydroxyalkylgruppe oder eine Polyhydroxyalkylgruppe oder eine gegebenenfalls substituierte (C₁-C₆)-Alkylengruppe, oder einen (C₁-C₆)-Acylrest, wobei bevorzugte Reste unabhängig voneinander ausgewählt sind aus -H, -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
R⁴ steht für -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
n steht für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10.It has been shown that certain quinones have particular suitability as a care enhancer. As a further care enhancer, the compositions according to the invention may therefore contain from 0.0001 to 5% by weight of at least one biochinone of the formula (Ubi)

contained in the
X, Y, Z are independently -O- or -NH- or NR ⁴ - or a chemical bond
R ¹ , R ² , R ³ independently of one another represent a hydrogen atom or an optionally substituted aryl group or an optionally substituted (C ₁ -C ₆ ) -alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C ₁ -C ₆ ) - Alkylene group, or a (C ₁ -C ₆ ) -acyl radical, preferred radicals being selected independently of one another from -H, -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
R ⁴ is -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
n stands for values from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.

in denen
R¹, R², R³ stehen jeweils unabhängig voneinander für -H, -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
R⁴ steht für -CH₃, oder -CH₂CH₃, oder -(CH₂)₂CH₂, oder -CH(CH₃)₂
n steht für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10.Preferred compounds of the formula (Ubi) according to the invention are, for example

in which
R ¹ , R ² , R ³ are each independently -H, -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
R ⁴ is -CH ₃ , or -CH ₂ CH ₃ , or - (CH ₂ ) ₂ CH ₂ , or -CH (CH ₃ ) ₂
n stands for values from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.

in der n für die Werte = 6, 7, 8, 9 oder 10, besonders bevorzugt für 10 (Coenzym Q10) steht.Particularly preferred hair cleansing compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% containing at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)

in which n stands for the values = 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).

in der n für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10 steht, wobei besonders bevorzugt Mittel Plastochinon PQ-9 der Formel

enthalten.As an alternative to the particularly preferred ubiquinones or in addition to them, the agents according to the invention may also contain plastoquinones. Here, preferred agents according to the invention are characterized in that they are 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ubi-b)

in which n stands for values of 1 to 20, preferably of 2 to 15 and in particular for 5, 6, 7, 8, 9, 10, whereby particularly preferred means Plastochinon PQ-9 of the formula

contain.

When further care enhancers may be the inventive Means Ectoin included. Ectoine ((4S) -2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes. The strongly water-binding low molecular weight organic compound occurs in halophilic bacteria and allows them to survive extremophilic organisms under stress conditions. According to the invention preferred hair cleanser are characterized in that they - related on their weight - 0.001 to 10% by weight, preferably 0.01 to 5 wt .-%, particularly preferably 0.05 to 2.5 wt .-% and in particular 0.1 to 1% by weight of (S) -2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (Ectoin) and the physiologically acceptable salts of these Compound and / or (S, S) -5-hydroxy-2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (Hydroxyectoine) and the physiologically acceptable salts this compound, included.

One Another nurse enhancer is allantoin. Allantoin (5-ureido-hydantoin, N- (2,5-dioxo-4-imidazolidinyl) urea) is at various Animal species, especially in mammals, in addition to uric acid the end product of the degradation of nucleic acids, especially of Purine bases.

allantoin is used in cosmetics in skin creams, sunscreens, shaving waters, in toothpaste and in remedies against excessive Perspiration (hyperhidrosis) and skin irritations used. It causes the acceleration of cell building, cell formation or cell regeneration and soothes the skin. Also the cure hard-healing wounds is supported, but possesses Allantoin no antiseptic properties.

invention contain particularly preferred hair cleanser - related on their weight - 0.001 to 10% by weight, preferably 0.01 to 5 wt .-%, particularly preferably 0.05 to 2.5 wt .-% and in particular 0.1 to 1% by weight of 5-ureidohydantoin (allantoin).

to Improvement of elasticity and strengthening of the inner Structure of treated with agents of the invention Hair can the agents of the invention Purine and / or purine derivatives as a care enhancer included. Especially the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones as a care enhancer causes that the treated with appropriate means hair, among others higher values for differential thermal analysis and show improved wet and dry combabilities.

Purine (7H-imidazo [4,5-d] pyrimidine) does not occur freely in nature, but forms the main body of purines. Purines, in turn, are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH ₂ , SH at the 2-, 6-, and 8-positions and / or with CH ₃ in 1-, 3-, 7-position derived. Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.

preferred agents according to the invention contain purine and / or Purine derivatives in narrower ranges. Here are preferred according to the invention Cosmetic compositions characterized in that they - related on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s) included.

in der die Reste R¹, R² und R³ unabhängig voneinander ausgewählt sind aus -H, -OH, NH₂, -SH und die Reste R⁴, R⁵ und R⁶ unabhängig voneinander ausgewählt sind aus -H, -CH₃ und -CH₂-CH₃, wobei folgende Verbindungen bevorzugt sind:

• – Purin (R¹ = R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – Adenin (R¹ = NH₂, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – Guanin (R¹ = OH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Harnsäure (R¹ = R² = R³ = OH, R⁴ = R⁵ = R⁶ = H)
• – Hypoxanthin (R¹ = OH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Purinthiol (R¹ = SH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Thioguanin (R¹ = SH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Xanthin (R¹ = R² = OH, R³ = R⁴ = R⁵ = R⁶ = H)
• – Coffein (R¹ = R² = OH, R³ = H, R⁴ = R⁵ = R⁶ = CH₃)
• – Theobromin (R¹ = R² = OH, R³ = R⁴ = H, R⁵ = R⁶ = CH₃)
• – Theophyllin (R¹ = R² = OH, R³ = H, R⁴ = CH₃, R⁵ = CH₃, R⁶ = H).

Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. According to the invention preferred hair cleansers are characterized in that they are used as care enhancers - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt. % and in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s), wherein preferred agents purine and / or purine derivative (s) of the formula (Pur-I)

in which the radicals R ¹ , R ² and R ^{3 are} independently selected from -H, -OH, NH ₂ , -SH and the radicals R ⁴ , R ⁵ and R ^{6 are} independently selected from -H, -CH ₃ and -CH ₂ -CH ₃ , where the following compounds are preferred:

• Purine (R ¹ = R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Adenine (R ¹ = NH ₂ , R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Guanine (R ¹ = OH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Uric acid (R ¹ = R ² = R ³ = OH, R ⁴ = R ⁵ = R ⁶ = H)
• Hypoxanthine (R ¹ = OH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-purethiol (R ¹ = SH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-thioguanine (R ¹ = SH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Xanthine (R ¹ = R ² = OH, R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Caffeine (R ¹ = R ² = OH, R ³ = H, R ⁴ = R ⁵ = R ⁶ = CH ₃ )
• - Theobromine (R ¹ = R ² = OH, R ³ = R ⁴ = H, R ⁵ = R ⁶ = CH ₃ )
• Theophylline (R ¹ = R ² = OH, R ³ = H, R ⁴ = CH ₃ , R ⁵ = CH ₃ , R ⁶ = H).

It is also advantageous, purine or purine derivatives and biochinones in a certain relationship to each other. Here, agents according to the invention are preferred in the weight ratio of purine (derivative (s)) and Biochinone (s) 10: 1 to 1: 100, preferably 5: 1 to 1:50, especially preferably 2: 1 to 1:20 and in particular 1: 1 to 1:10.

As already mentioned, caffeine is a particularly preferred Purine derivative, and the coenzyme Q10 is a particularly preferred Bioquinone. Particularly preferred invention Means are therefore characterized in that they - related on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1% by weight of caffeine and 0.0002 to 4% by weight, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, further preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.

When Nursing enhancers may be the invention Agents also contain flavonoids. The flavonoids are a group of water-soluble plant dyes and play one important role in the metabolism of many plants. you belong along with the phenolic acids to the polyphenols. There are Well over 6,500 different flavonoids are known into flavonols, flavones, flavanones, isoflavonoids and anthocyanins to divide.

According to the invention, flavonoids from all six groups can be used, with certain representatives from the individual groups being preferred as care enhancers because of their particularly intensive action. Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, Delphinidin, malvidin, pelargonidin, peonidin, petunidin.

Particularly according to the invention preferred hair cleansers are characterized in that they - related on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1 wt .-% flavonoids, in particular flavonols, particularly preferred 3,3 ', 4', 5,7-pentahydroxyflavone (quercetin) and / or 3,3 ', 4', 5,7-pentahydroxyflavone-3-O-rutinoside (rutin), contain.

enthalten.Preference is also the use of bisabolol and / or bisabololoxides as care enhancers in the inventive compositions. Hair-cleansing compositions according to the invention which additionally contain 0.001 to 5 wt.%, Preferably 0.01 to 4 wt.%, Particularly preferably 0.02 to 2.5 wt.% And in particular 0.1 to 1.5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol

contain.

Also Creatine is suitable according to the invention as a care enhancer. Creatine (3-methylguanidinoacetic acid) is an organic Acid present in vertebrates u. a. to supply the muscles contributes with energy. Creatine is in the kidney, the liver and synthesized in the pancreas. She leads Formally derived from the amino acids glycine and arginine is 95% present in skeletal muscle. Particularly preferred invention Hair cleansers contain - based on their weight - 0.01 to 15% by weight, preferably 0.025 to 12.5% by weight, more preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5 wt .-% and in particular 0.5 to 5 wt .-% N-methyl-guanidino-acetic acid (creatine).

The compositions according to the invention may contain, in addition to the ingredients mentioned above and optional further ingredients, other substances which prevent, alleviate or cure hair loss. In particular, a content of hair root stabilizing agents is advantageous. These substances are described below:
Propecia (Finasteride) is currently the only preparation that is approved worldwide and has been proven in many studies to be effective and tolerable. Propecia causes less DHT to form from testosterone.

minoxidil is probably the oldest with or without supplementary additives proven hair restorer. For the treatment of hair loss it may only be used for external application. There are hair lotions that contain 2% -5% minoxidil, as well Gels with up to 15% minoxidil.

The Efficacy increases with the dosage, in hair waters is Minoxidil but only up to 5% share soluble. In many countries Hair Lotion with up to 2% Minoxidil content are prescription free available.

to Combating hormonal effects on The hair follicle may be used externally for spironolactone applied in the form of hair tonic and in combination with minoxidil become. Spironolactone acts as an androgen receptor blocker, ie. the binding of DHT to the hair follicles is prevented.

In summary hair treatment compositions according to the invention are preferred, the additional - based on its weight - 0.001 up to 5% by weight hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.

By additional antidandruff active ingredients (for example climbazole, Piroctone oil amines or zinc pyrithione) will increase the amount of Shed-causing yeast specifically reduces the germ flora again reaches the normal percentage composition and the Desquamation is reduced to the physiological level. However, laboratory tests have proven that the different Species representatives of the Pityrosporum ovale do well on the Antidandruff active ingredients react. To maximize all dandruff To fight is therefore a combination of anti-dandruff agents most successful.

In summary hair cleansers according to the invention are preferred, the additional - based on their weight - 0.001 to 5% by weight of anti-dandruff active ingredients, in particular Piroctone oil amines (1-hydroxy-4-methyl-6- (2,4,4-trirnethylpentyl) pyridin-2 (1H) -one, Compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or Selenium sulfide and / or climbazole and / or salicylic acid or Contain fumaric acid.

additionally to the care enhancers can di according to the invention Means contain further care substances. Their presence is for the achievement of the effects of the invention not absolutely necessary, but further effects, like a pleasant grip or a pleasant application feel result from the use of these care substances.

When another ingredient can the inventive Agent with particular preference one or more amino acids contain. Particularly preferred according to the invention usable amino acids are from the group glycine, Alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, Proline, aspartic acid, glutamic acid, asparagine, Glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β-alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline (L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, where Both the individual amino acids and mixtures are used can.

preferred Compositions according to the invention contain one or more Amino acids in narrower ranges. Here are preferred according to the invention Hair cleansing agent, characterized in that it - as a care - related on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1.5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% Amino acid (s), preferably from the group glycine and / or Alanain and / or valine and / or lysine and / or leucine and / or threonine contain.

• – Monosachhariden, insbesondere – D-Ribose und/oder – D-Xylose und/oder – L-Arabinose und/oder – D-Glucose und/oder – D-Mannose und/oder – D-Galactose und/oder – D-Fructose und/oder – Sorbose und/oder – L-Fucose und/oder – L-Rhamnose
• – Disacchariden, insbesondere – Saccharose und/oder – Maltose und/oder – Lactose und/oder – Trehalose und/oder – Cellobiose und/oder – Gentiobiose und/oder – Isomaltose.

As a further component, the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides. Here are preferred hair treatment compositions according to the invention characterized in that they are used as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out

• Monosaccharides, in particular D-ribose and / or D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L-fucose and / or L-rhamnose
• - Disaccharides, in particular - sucrose and / or - maltose and / or - lactose and / or - trehalose and / or - cellobiose and / or - gentiobiose and / or - isomaltose.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose.

Particularly preferred agents according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose.

As already mentioned, contain preferred inventive Middle (one) amino acid (s).

Particularly according to the invention preferably usable amino acids are from the group Glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, Tryptophan, proline, aspartic acid, glutamic acid, Asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, Arginine, histidine, β-alanine, 4-aminobutyric acid (GABA), Betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline (L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, where both the individual amino acids as well as mixtures can be used.

preferred Compositions according to the invention contain one or more Amino acids in narrower ranges. Here are preferred according to the invention Cosmetic agents, characterized in that they additionally - 0.05 to 5 wt .-%, preferably 0.1 to 2.5 wt .-%, more preferably 0.15 to 1% by weight and in particular 0.2 to 0.5% by weight of amino acid (s), preferably (an) amino acid (s) from the group glycine and / or Alanain and / or valine and / or lysine and / or leucine and / or threonine contain.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Valin.

Particularly preferred agents according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of valine.

A particularly preferred group of ingredients are the silicones represents.

• (i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind;
• (ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: a) substituierten oder unsubstituierten aminierten Gruppen; b) (per)fluorierten Gruppen; c) Thiolgruppen; d) Carboxylatgruppen; e) hydroxylierten Gruppen; f) alkoxylierten Gruppen; g) Acyloxyalkylgruppen; h) amphoteren Gruppen; i) Bisulfitgruppen; j) Hydroxyacylaminogruppen; k) Carboxygruppen; l) Sulfonsäuregruppen; und m) Sulfat- oder Thiosulfatgruppen;
• (iii) linearen Polysiloxan(A)-Polyoxyalkylen(B)-Blockcopoylmeren vom Typ (A-B)_n mit n > 3;
• (iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde;
• (v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält;

oder deren Gemischen.Preferred agents according to the invention are characterized in that they comprise at least one silicone, preferably a silicone, selected from:

• (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
• (ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; l) sulfonic acid groups; and m) sulfate or thiosulfate groups;
• (iii) linear polysiloxane (A) polyoxyalkylene (B) block copolymers of the (AB) _{n type} with n>3;
• (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
• (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;

or their mixtures.

Particularly according to the invention preferred agents preferably contain the silicone (s) in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5 wt .-%, each based on the total Medium.

preferred Silicones are described below.

Particularly preferred agents according to the invention are characterized in that they contain at least one silicone of the formula Si-I (CH ₃ ) ₃ Si- [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

These silicones are called DIMETHICONE according to the INCI nomenclature. In the context of the present invention, as the silicone of the formula Si-1, the compounds are preferably:
(CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₀ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₁ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₈ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂₀ -O-Si (CH ₃ ) ₃
where (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃ and / or (CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) _{3 are} particularly preferred.

Of course can also mixtures of o. g. Silicones in the invention Be included means.

Preferred silicones which can be used according to the invention have viscosities of from 0.2 to 2 mm ² s ^-1 at 20 ° C., silicones having viscosities of from 0.5 to 1 mm ² s ^{-1 being} particularly preferred.

Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may, for. B. by the formula M (R _a Q _b SiO _{(4a-b) / 2) x} (R _c SiO _{(4-c) / 2) y} M wherein R in the above formula is a hydrocarbon or a hydrocarbon group of 1 to about 6 carbon atoms, Q is a polar group of the general formula -R ¹ HZ wherein R ^{1 is} a divalent linking group attached to hydrogen and the group Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "A" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _z (CH ₂ ) _zz NH, wherein both z and zz are independently 1 or more, which structure includes diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (CH ₂ ) _z (CH ₂ ) _zz NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "Is a number in the range of about 1 to about 3. The molar ratio of the R _a Q _b SiO _{(4-ab) / 2} units to the R _c SiO _{(4-c) / 2} units is in the range of about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are used, the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

• – G ist -H, eine Phenylgruppe, -OH, -O-CH₃, -CH₃, -O-CH₂CH₃, -CH₂CH₃, -O-CH₂CH₂CH₃, -CH₂CH₂CH₃, -O-CH(CH₃)₂, -CH(CH₃)₂, -O-CH₂CH₂CH₂CH₃, -CH₂CH₂CH₂CH₃, -O-CH₂CH(CH₃)₂, -CH₂CH(CH₃)₂, -O-CH(CH₃)CH₂CH₃, -CH(CH₃)CH₂CH₃, -O-C(CH₃)₃, -C(CH₃)₃;
• – a steht für eine Zahl zwischen 0 und 3, insbesondere 0;
• – b steht für eine Zahl zwischen 0 und 1, insbesondere 1,
• – m und n sind Zahlen, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt,
• – R' ist ein monovalenter Rest ausgewählt aus – -Q-N(R'')-CH₂-CH₂-N(R'')₂ – -Q-N(R'')₂ – -Q-N⁺(R'')₃A^– – -Q-N⁺H(R'')₂ A^– – -Q-N⁺H₂(R'') A^– – -Q-N(R'')-CH₂-CH₂-N⁺R''H₂A^–, wobei jedes Q für eine chemische Bindung, -CH₂-, -CH₂-CH₂-, -CH₂CH₂CH₂-, -C(CH₃)₂-, -CH₂CH₂CH₂CH₂-, -CH₂C(CH₃)₂-, -CH(CH₃)CH₂CH₂- steht, R'' für gleiche oder verschiedene Reste aus der Gruppe -H, -Phenyl, -Benzyl, -CH₂-CH(CH₃)Ph, der C_1-20-Alkylreste, vorzugsweise -CH₃, -CH₂CH₃, -CH₂CH₂CH₃, -CH(CH₃)₂, -CH₂CH₂CH₂H₃, -CH₂CH(CH₃)₂, -CH(CH₃)CH₂CH₃, -C(CH₃)₃, steht und A ein Anion repräsentiert, welches vorzugsweise ausgewählt ist aus Chlorid, Bromid, Iodid oder Methosulfat.

Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (Si-II) R _'a G _3-a -Si (OSiG _{2) n} - (OSiG _b R' _{2-b) m} -O-SiG _3-a -R'a (Si-II), contain, in which means:

• G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH (CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -OC (CH ₃ ) ₃ , -C (CH ₃ ) ₃ ;
• A is a number between 0 and 3, in particular 0;
• B is a number between 0 and 1, in particular 1,
• M and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
• R 'is a monovalent radical selected from --QN (R'') - CH ₂ -CH ₂ -N (R'') ₂ - -QN (R'') ₂ - -QN ⁺ (R'') ₃ A ^- - -QN ⁺ H (R '') ₂ A ^- - -QN ⁺ H ₂ (R '') A ^- - -QN (R '') - CH ₂ -CH ₂ -N ⁺ R''H ₂ A ^- , where each Q is a chemical bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -, R '' is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C (CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These Silicones are classified as trimethylsilylamodimethicones according to the INCI declaration designated.

enthalten, worin R für -OH, -O-CH₃ oder eine -CH₃-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Also particularly preferred are agents according to the invention which are an amino-functional silicone of the formula (Si-IIb)

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These Silicones are called amodimethicones according to the INCI declaration.

Independently of which amino-functional silicones are used are agents according to the invention which are an amino-functional Silicone contain its amine number above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g. The amine number stands for the milliequivalents Amine per gram of amino-functional silicone. It can be done by titration determined and also in the unit mg KOH / g.

According to the invention preferred Agents are characterized by having 0.01, based on their weight to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and in particular 0.5 to 5% by weight of amino-functional (s) Silicone (s) included.

enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von 30 bis 7 und insbesondere 3, 4, 5 oder 6, steht.The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here, agents according to the invention are preferred which contain at least one silicone of the formula Si-III

in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 30 to 7 and in particular 3, 4, 5 or 6.

The silicones described above have a backbone, which is composed of -Si-O-Si units. Of course These Si-O-Si units can also be replaced by carbon chains be interrupted. Corresponding molecules are by chain extension reactions accessible and preferably come in the form of silicone-in-water emulsions for use.

Agents which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula Si-IV R ₃ Si [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-IV), in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , - C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.

With The silicones are preferably water-soluble. According to the invention preferred Means are characterized by being at least contain a water-soluble silicone.

From aesthetic Reasons become "clear" products of consumers often preferred. Hair treatment agents preferred according to the invention are therefore characterized by being transparent or translucent.

Under transparent or translucent is within the scope of the present invention understood a composition having an NTU value of less than 100 having. The NTU value (Nephelometric Turbidity Unit, Nephelometric Turbidity value, NTU) is one used in water treatment Unit for turbidity measurements in liquids. It is the unit of a measured with a calibrated nephelometer Turbidity of a liquid.

Farther may in a preferred embodiment of the invention an agent according to the invention also UV filter (I) contain. The invention to be used UV filters are subject to structural and physical considerations Features no general restrictions. Much more All UV filters that can be used in the cosmetics sector are suitable Absorption maximum in UVA (315-400 nm) -, in UVB (280-315 nm) - or in the UVC (<280 nm) range. UV filter with an absorption maximum in the UVB range, especially in the range of about 280 to about 300 nm, are particularly prefers.

The According to the invention used UV filter for example, be selected from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic esters, Cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.

Examples of UV filters which can be used according to the invention are 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline-methylsulfate, 3,3,5-trimethyl-cyclohexylsalicylate (homosalates), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ^® M 40, Uvasorb MET ^{®, ®} Neo Heliopan BB, Eusolex ^® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ^® HS; Neo Heliopan Hydro ^®), 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1- yl-methane sulfonic acid) and salts thereof, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) Methoxydibenzoylmethane -propane-1,3-dione (butyl; Parsol ^® 1789 Eusolex ^® 9020), α - (2-oxoborn-3-ylidene) toluene-4-sulfonic acid and salts thereof, ethoxylated 4-aminobenzoic acid ethyl ester (PEG-25 PABA; Uvinul ^® P 25), 4-dimethylaminobenzoic acid 2-ethylhexyl (octyl dimethyl PABA; Uvasorb ^® DMO, Escalol ^® 507, Eusolex ^® 6007), salicylic acid-2-ethylhexy ester (octyl salicylate; Escalol ^® 587, Neo Heliopan ^® OS, Uvinul ^® O18), 4-methoxycinnamic acid isopentyl (isoamyl p-methoxycinnamate; Neo Heliopan ^® E 1000), 4-methoxycinnamic acid 2-ethylhexyl ester (Octyl Methoxycinnamate; Parsol ^® MCX, Escalol ^® 557 , Neo Heliopan AV ^®), 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt (Benzophenone-4; Uvinul ^® MS 40; Uvasorb S 5 ^®), 3- (4'-methylbenzylidene) -D, L- camphor (4-methylbenzylidene camphor; Parsol ^® 5000, Eusolex ^® 6300), 3-benzylidene camphor (3-benzylidene camphor), 4-isopropylbenzyl, 2,4,6-trianilino- (p-carbo-2'-ethylhexyl 1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2-oxoborn-3-ylidenemethyl] benzyl} - acrylamide, 2,4-dihydroxy (benzophenone-1; Uvasorb ^® 20 H, Uvinul ^® 400), 1,1'-Diphenylacrylonitrilsäure-2-ethylhexyl ester (Octocrylene; Eusolex ^® OCR, Neo Heliopan ^® Type 303, Uvinul ^® N 539 SG), o-aminobenzoic acid menthyl ester (menthyl anthranilate; Neo Hel iopan ^® MA), 2,2 ', 4,4'-tetrahydroxy benzophenone (benzophenone-2; Uvinul ^® D-50), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone (Benzophenone-6), 2,2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sodium sulfonate, and 2-cyano-3, 3-diphenylacrylate 2'-ethylhexyl acrylate. Preference is given to 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone , 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo-bicyclo- [2.2.1] hept-1-yl-methanesulfonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, α- (2-oxoborn-3-yl) yliden) -toluene-4-sulfonic acid and its salts, ethoxylated 4-aminobenzoic acid ethyl ester, 2-ethylhexyl 4-dimethylaminobenzoate, 2-ethylhexyl salicylate, isopentyl 4-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate, 2 Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt, 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 4-isopropylbenzylsalicylate, 2,4,6-trianilino- (p-) carbo-2'-ethylhexyl-1'-oxi) -1,3,5-triazine, 3-imidazol-4-yl-acrylic acid and its ethyl ester, polymers of N - {(2 and 4) - [2- oxoborn-3-ylidenemethyl] benzyl} acrylamide. Very particularly preferred according to the invention are 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane-1,3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.

Prefers are those UV filters whose molar extinction coefficient at the absorption maximum above 15,000, especially above 20,000.

Farther was found to be structurally similar UV filters in many cases, the water-insoluble Compound within the scope of the teaching of the invention the higher effect over such water-soluble Compounds that are distinguished from it by one or more additionally differentiate ionic groups. As water insoluble Within the scope of the invention, UV filters are to be understood which at 20 ° C to not more than 1 wt .-%, in particular to not more than 0.1% by weight, dissolve in water. Farther These compounds should be used in usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-% be soluble). The use of water-insoluble UV filter can therefore be preferred according to the invention be.

According to one Another embodiment of the invention are those UV filters preferably a cationic group, in particular a quaternary Ammonium group.

These UV filters have the general structure U-Q.

• – substituierte Benzophenone,
• – p-Aminobenzoesäureester,
• – Diphenylacrylsäureester,
• – Zimtsäureester,
• – Salicylsäureester,
• – Benzimidazole und
• – o-Aminobenzoesäureester.

The structural part U stands for a UV-absorbing group. This group can in principle be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is replaced by a cationic group Q, in particular having a quaternary amino function , Compounds from which the structural part U can derive are, for example

• Substituted benzophenones,
• P-aminobenzoic acid ester,
• - diphenylacrylic acid ester,
• - cinnamic acid ester,
• Salicylic acid ester,
• Benzimidazoles and
• O-aminobenzoic acid ester.

structural parts U, derived from cinnamic acid amide or N, N-dimethylamino-benzoic acid amide derive, are preferred according to the invention.

The Structural parts U can be chosen in principle be that the absorption maximum of the UV filter both in the UVA (315-400 nm) - as well as in the UVB (280-315 nm) - or in UVC (<280 nm) range can be. UV filter with an absorption maximum in the UVB range, especially in the range of about 280 to about 300 nm, are particularly preferred.

Farther becomes the structural part U, also depending on structural part Q, preferably chosen so that the molar extinction coefficient of the UV filter at the absorption maximum above 15,000, in particular above from 20000, lies.

Of the Structural part Q preferably contains as a cationic group a quaternary ammonium group. This quaternary ammonium group can in principle be connected directly to the structural part U, so the structural part U is one of the four substituents of the represents a positively charged nitrogen atom. However, it is preferred one of the four substituents on the positively charged nitrogen atom a group, in particular an alkylene group having 2 to 6 carbon atoms, as the connection between the structural part U and the positively charged Nitrogen atom acts.

Advantageously, the group Q has the general structure - (CH ₂ ) _X -N ⁺ R ¹ R ² R ³ X ^- , in which x is an integer from 1 to 4, R ¹ and R ² independently of one another are C _{1 -4} alkyl groups, R ³ is a C _1-22 alkyl group or a benzyl group and X ^{- is} a physiologically acceptable anion. In the context of this general structure, x preferably represents the number 3, R ¹ and R ² each represent a methyl group and R ^{3 represents} either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms.

physiological Compatible anions are, for example, inorganic anions such as halides, especially chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, Tartrate, methosulfate and tosylate.

Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid trimethyl ammonium chloride (Incroquat ^® UV-283) and Dodecyldimethylaminobenzamidopropyl-tosylate (Escalol ^® HP 610).

Of course includes the teaching of the invention also the use of a combination of multiple UV filters. As part of In this embodiment, the combination is at least one water-insoluble UV filter with at least one UV filter preferred with a cationic group.

The UV filters (I) are customary in the compositions according to the invention in amounts of 0.1-5% by weight, based on the total agent, contain. Levels of 0.4-2.5 wt .-% are preferred.

The compositions of the invention may further contain a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J). Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C ₁ - to C ₄ -alkyl groups. The sodium salt is most preferred. The amounts used in the compositions according to the invention are preferably 0.05 to 10 wt .-%, based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt .-%.

additionally It may prove advantageous if in the inventive Agents contain penetration aids and / or swelling agents (M) are. These include, for example, urea and Urea derivatives, guanidine and its derivatives, arginine and its Derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ether, Propylene glycol and propylene glycol ether, for example propylene glycol monoethyl ether, Carbonates, bicarbonates, diols and triols, and in particular 1,2-diols and 1,3-diols such as 1,2-propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-dodecanediol, 1,3-propanediol, 1,6-hexanediol, 1,5-pentanediol, 1,4-butanediol.

Advantageous For the purposes of the invention may additionally short-chain Carboxylic acids (N) support the active ingredient complex (A). Among short-chain carboxylic acids and their derivatives in the For the purposes of the invention, carboxylic acids are understood which saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic may be and have a molecular weight less than 750. For the purposes of the invention, preference may be given to saturated or unsaturated straight-chain or branched carboxylic acids with a chain length of 1 to 16 C atoms in the chain be particularly preferred are those with a chain length from 1 to 12 C atoms in the chain.

The short-chain carboxylic acids in the context of the invention have one, two, three or more carboxy groups. Preferred in Meaning of the invention are carboxylic acids having a plurality of carboxy groups, especially di- and tricarboxylic acids. The carboxy groups may be used, in whole or in part, as ester, acid anhydride, lactone, Amide, imidic acid, lactam, lactim, dicarboximide, carbohydrazide, Hydrazone, hydroxam, hydroxime, amidine, amidoxime, nitrile, phosphonated or phosphate ester. The inventively used Of course, carboxylic acids can be used substituted along the carbon chain or ring skeleton be. To the substituents of the invention used Carboxylic acids are, for example, C 1 -C 8 -alkyl-, C 2 -C 8 -alkenyl-, Aryl, aralkyl and aralkenyl, hydroxymethyl, C2-C8 hydroxyalkyl, C2-C8-hydroxyalkenyl, aminomethyl, C2-C8-aminoalkyl, cyano, Formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or Imino groups. Preferred substituents are C 1 -C 8 -alkyl-, hydroxymethyl-, Hydroxy, amino and carboxy groups. Particularly preferred are substituents in ☐ position. Very particularly preferred substituents are hydroxy, alkoxy and amino groups, wherein the amino function optionally by alkyl, aryl, aralkyl and / or alkenyl radicals can be further substituted. Furthermore, they are also preferred Carboxylic acid derivatives, the phosphonic and phosphate esters.

• – Anlagerungsprodukte von 4 bis 30 Mol Ethylenoxid und/oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe,
• – C₁₂-C₂₂-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Polyole mit 3 bis 6 Kohlenstoffatomen, insbesondere an Glycerin,
• – Ethylenoxid- und Polyglycerin-Anlagerungsprodukte an Methylglucosid-Fettsäureester, Fettsäurealkanolamide und Fettsäureglucamide,
• – C₈-C₂₂-Alkylmono- und -oligoglycoside und deren ethoxylierte Analoga, wobei Oligomerisierungsgrade von 1,1 bis 5, insbesondere 1,2 bis 2,0, und Glucose als Zuckerkomponente bevorzugt sind,
• – Gemische aus Alkyl-(oligo)-glucosiden und Fettalkoholen zum Beispiel das im Handel erhältliche Produkt Montanov^®68,
• – Anlagerungsprodukte von 5 bis 60 Mol Ethylenoxid an Rizinusöl und gehärtetes Rizinusöl,
• – Partialester von Polyofen mit 3-6 Kohlenstoffatomen mit gesättigten Fettsäuren mit 8 bis 22 C-Atomen,
• – Sterine. Als Sterine wird eine Gruppe von Steroiden verstanden, die am C-Atom 3 des Steroid-Gerüstes eine Hydroxylgruppe tragen und sowohl aus tierischem Gewebe (Zoosterine) wie auch aus pflanzlichen Fetten (Phytosterine) isoliert werden. Beispiele für Zoosterine sind das Cholesterin und das Lanosterin. Beispiele geeigneter Phytosterine sind Ergosterin, Stigmasterin und Sitosterin. Auch aus Pilzen und Hefen werden Sterine, die sogenannten Mykosterine, isoliert.
• – Phospholipide. Hierunter werden vor allem die Glucose-Phospolipide, die z. B. als Lecithine bzw. Phospahtidylcholine aus z. B. Eidotter oder Pflanzensamen (z. B. Sojabohnen) gewonnen werden, verstanden.
• – Fettsäureester von Zuckern und Zuckeralkoholen, wie Sorbit,
• – Polyglycerine und Polyglycerinderivate wie beispielsweise Polyglycerinpoly-12-hydroxystearat (Handelsprodukt Dehymuls^® PGPH),
• – Lineare und verzweigte Fettsäuren mit 8 bis 30 C-Atomen und deren Na-, K-, Ammonium-, Ca-, Mg- und Zn-Salze.

In a further preferred embodiment, the agents according to the invention may contain emulsifiers (F). Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion. Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions. An emulsion is to be understood as meaning a droplet-like distribution (dispersion) of a liquid in another liquid under the expense of energy in order to create stabilizing phase interfaces by means of surfactants. The selection of these emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion. Emulsifiers which can be used according to the invention are, for example

• - Addition products of 4 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear Fettal alcohols containing 8 to 22 carbon atoms, fatty acids containing 12 to 22 carbon atoms and alkylphenols having 8 to 15 carbon atoms in the alkyl group,
• C ₁₂ -C ₂₂ -fatty acid mono- and diesters of addition products of from 1 to 30 mol of ethylene oxide onto polyols having from 3 to 6 carbon atoms, in particular to glycerol,
• Ethylene oxide and polyglycerol addition products to methyl glucoside fatty acid esters, fatty acid alkanolamides and fatty acid glucamides,
• C ₈ -C ₂₂ -alkylmono- and -oligoglycosides and their ethoxylated analogues, preference being given to degrees of oligomerization of from 1.1 to 5, in particular from 1.2 to 2.0, and glucose as the sugar component,
• Glucosides mixtures of alkyl (oligo) and fatty alcohols, for example, the commercially available product ^® Montanov 68, -
• Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil,
• Partial esters of polyofen having 3-6 carbon atoms with saturated fatty acids having 8 to 22 carbon atoms,
• - sterols. Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
• - Phospholipids. These include, above all, the glucose phospholipids, which are z. B. as lecithins or Phospahtidylcholine from z. Egg yolks or plant seeds (eg soybeans) are understood.
• Fatty acid esters of sugars and sugar alcohols, such as sorbitol,
• - polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ^® PGPH),
• - Linear and branched fatty acids with 8 to 30 carbon atoms and their Na, K, ammonium, Ca, Mg and Zn salts.

The agents according to the invention contain the emulsifiers preferably in amounts of 0.1-25 wt .-%, in particular 0.5-15 Wt .-%, based on the total agent.

Prefers can the compositions of the invention at least one nonionic emulsifier having an HLB value of 8 to 18 included. Nonionic emulsifiers with an HLB value from 10-15 can according to the invention especially be preferred.

When Furthermore, it has been shown to be advantageous if, in addition to the polymer (s) from the group of cationic and / or amphoteric polymers further polymers (G) in the inventive compositions are included. In a preferred embodiment the inventive compositions therefore more polymers added, both anionic and nonionic polymers have proved effective.

at the anionic polymers (G2) are anionic polymers, which have carboxylate and / or sulfonate groups. Examples for anionic monomers that make up such polymers can, are acrylic acid, methacrylic acid, Crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups can be used in whole or in part as Sodium, potassium, ammonium, mono- or triethanolammonium salt available. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.

When anionic polymers have proven to be particularly effective as the sole or co-monomer 2-acrylamido-2-methylpropanesulfonic acid contain, wherein the sulfonic acid group completely or partially as sodium, potassium, ammonium, mono- or triethanolammonium salt may be present.

More preferably, the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid, which is available for example under the name Rheothik ^® 11-80 is commercially.

Within In this embodiment, it may be preferable to use copolymers from at least one anionic monomer and at least one nonionic Use monomer. Regarding the anionic monomers Reference is made to the substances listed above. preferred non-ionic monomers are acrylamide, methacrylamide, acrylic esters, Methacrylic acid esters, vinylpyrrolidone, vinyl ethers and vinyl esters.

Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mole percent acrylamide and 30 to 45 mole percent 2-acrylamido-2-methylpropane sulfonic acid, wherein the sulfonic acid group is wholly or partially present as sodium, potassium, ammonium, mono- or triethanolammonium salt. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C ₁₃ -C ₁₄ isoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention.

Also sold under the name Simulgel ^® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.

Likewise preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ^® commercially.

Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers. A 1.9-decadienes crosslinked maleic acid-methyl copolymer available under the name Stabileze® ^® QM.

The agents according to the invention can be used in one further embodiment nonionogenic polymers (G4).

• – Vinylpyrrolidon/Vinylester-Copolymere, wie sie beispielsweise unter dem Warenzeichen Luviskol^® (BASF) vertrieben werden. Luviskol^® VA 64 und Luviskol^® VA 73, jeweils Vinylpyrrolidon/Vinylacetat-Copolymere, sind ebenfalls bevorzugte nichtionische Polymere.
• – Celluloseether, wie Hydroxypropylcellulose, Hydroxyethylcellulose und Methylhydroxypropylcellulose, wie sie beispielsweise unter den Warenzeichen Culminal^® und Benecel^® (AQUALON) und Natrosol^®-Typen (Hercules) vertrieben werden.
• – Stärke und deren Derivate, insbesondere Stärkeether, beispielsweise Structure^® XL (National Starch), eine multifunktionelle, salztolerante Stärke;
• – Schellack
• – Polyvinylpyrrolidone, wie sie beispielsweise unter der Bezeichnung Luviskol^® (BASF) vertrieben werden.
• – Siloxane. Diese Siloxane können sowohl wasserlöslich als auch wasserunlöslich sein. Geeignet sind sowohl flüchtige als auch nichtflüchtige Siloxane, wobei als nichtflüchtige Siloxane solche Verbindungen verstanden werden, deren Siedepunkt bei Normaldruck oberhalb von 200°C liegt. Bevorzugte Siloxane sind Polydialkylsiloxane, wie beispielsweise Polydimethylsiloxan, Polyalkylarylsiloxane, wie beispielsweise Polyphenylmethylsiloxan, ethoxylierte Polydialkylsiloxane sowie Polydialkylsiloxane, die Amin- und/oder Hydroxy-Gruppen enthalten.
• – Glycosidisch substituierte Silicone.

Suitable nonionic polymers are, for example:

• - Vinylpyrrolidone / vinyl ester copolymers, such as those sold under the trademark Luviskol ^® (BASF). Luviskol ^® VA 64 and Luviskol ^® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
• - cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as for example under the trademark Culminal® ^® and Benecel ^® (AQUALON) and Natrosol ^® grades (Hercules) are distributed.
• - starch and its derivatives, in particular starch, such as Structure XL ^® (National Starch), a multifunctional, salt-tolerant starch;
• - shellac
• - polyvinylpyrrolidones, as for example under the name Luviskol ^® (BASF).
• - siloxanes. These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure. Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
• - Glycosidically substituted silicones.

It It is also possible according to the invention that the Preparations several, especially two different polymers same Charge and / or in each case an ionic and an amphoteric and / or contain nonionic polymer.

The other polymers (G) are in the inventive Agents preferably in amounts of 0.05 to 10 wt .-%, based on the entire remedy, included. Amounts of 0.1 to 5, in particular from 0.1 to 3% by weight are particularly preferred.

One Another object of the present invention is the use of plant extracts in PEG-free hair cleansers for improvement the smoothness and wet combability of keratinous fibers.

As already mentioned above, are pomegranate extracts Particularly preferred according to the invention, since these the combability, in particular the wet combability, keratinous fibers significantly improve and the fibers more fullness and give volume.

One Another object of the present invention is therefore the use of pomegranate extract in hair cleansers.

Especially serve preferred uses of the invention to improve the fullness and / or the volume and / or combability, in particular wet combability.

In terms of preferred embodiments of the invention Uses applies mutatis mutandis to the invention Means said.

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• WO 92/13829 [0092]

Cited non-patent literature

• - Page 44 of the 3rd edition of the guideline for the declaration of ingredients of cosmetic products, published by the German Association of Personal Care and Detergents e. V. (IKW), Frankfurt [0053]

Claims (16)

Hair-cleansing compositions containing, in a cosmetically acceptable vehicle, by weight, (a) 0.1 to 35% by weight of at least one surfactant, (b) 0.1 to 10% by weight of at least one plant extract, characterized in that there are no compounds of the formula (I) H- (O-CH ₂ CH ₂ ) _n -OH (I), in which n stands for integers between 1 and 100,000. Hair-cleansing composition according to claim 1, characterized in that there are no compounds of the formula (I)) H- (O-CH (CH ₃ ) CH ₂ ) _n -OH (II), in which n stands for integers between 1 and 100,000. Hair-cleansing composition according to one of claims 1 or 2, characterized in that it contains no compounds of the formula (IIII) R- (O-CH ₂ CH ₂ ) _n -OH (III), wherein R is any alkyl or alkenyl group and n is an integer between 1 and 10,000. Hair-cleansing composition according to one of Claims 1 to 3, characterized in that it contains no compounds of the formula (IV) R- (O-CH ₂ CH ₂ ) _n -OSO ₃ H (IV), wherein R is any alkyl or alkenyl group and n is an integer between 1 and 10,000. Hair-cleaning composition according to any one of claims 1 to 4, characterized in that there are no compounds containing the grouping of formula (V) - (O-CH ₂ CH ₂ ) _n - (V), in which n stands for integers between 2 and 100,000. Hair-cleaning composition according to one of claims 1 to 5, characterized in that it comprises amphoteric surfactant (s) from the groups of - N-alkylglycines, - N-alkylpropionic acids, - N-alkylaminobutyric acids, - N-alkyliminodipropionic acids, - N-hydroxyethyl N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids each having about 8 to 24 C atoms in the alkyl group, alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group, Cocoalkylaminopropionate, cocoacylaminoethylaminopropionate, C ₁₂ -C ₁₈ acylsarcosine, N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, 2-Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group - Kokosacylaminoethylhydroxyethylcarboxymethylglycinat - under the INCI name cocamidopropyl betaine known compounds, - Contains the compounds known under the INCI name Disodium Cocoamphodiacetate, wherein preferred means the amphoteric surfactant (s) in amounts of 0.5 to 9 wt .-%, preferably from 0.75 to 8 wt. -% and in particular from 1 to 7.5 wt .-%, each based on the total agent included. Hair-cleansing composition according to one of claims 1 to 6, characterized in that as amphoteric surfactants betaines of the formula (VI)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms Hair-cleansing composition according to one of Claims 1 to 7, characterized in that it contains as amphoteric surfactants betaines of the formula (VII)

in which R is a straight-chain or branched, saturated or mono- or polyunsaturated alkyl or alkenyl radical having 8 to 24 carbon atoms. Hair-cleansing composition according to one of claims 7 or 8, characterized in that the radical R in the formulas (VI) and (VII) is selected from - H ₃ C- (CH ₂ ) ₇ - - H ₃ C- (CH ₂ ) ₉ - - H ₃ C- (CH ₂ ) ₁₁ - - H ₃ C- (CH ₂ ) ₁₃ - - H ₃ C- (CH ₂ ) ₁₅ - - H ₃ C- (CH ₂ ) ₇ -CH = CH- ( CH ₂ ) ₇ - or mixtures of these. Hair cleanser according to one of claims 1 to 10, characterized in that it contains as nonionic surfactants alkylpolyglycosides of the general formula RO- (Z) _x , wherein R is alkyl, Z is sugar and x is the number of sugar units. Hair cleanser according to one of the claims 1 to 10, characterized in that it contains at least one extract from the group of extracts of i pomegranate, ii Roibos, iii Almond, iv Elderberry, contains. Hair cleanser according to one of claims 1 to 11, characterized in that it additionally contains at least one care enhancer from the group i. L-carnitine and / or its salts; ii. Panthenol and / or panthothenic acid; iii. the 2-furanones and / or their derivatives, in particular pantolactone; iv. Taurine and / or its salts; v. niacinamide; vi. ubiquinone vii. Ectoin; viii. allantoin; ix. Contains extracts of Echinacea. Hair cleanser according to claim 12, characterized in that that it or the care substance (s) - based on his Weight - in amounts of 0.001 to 10 wt .-%, preferably 0.005 to 7.5 wt .-%, particularly preferably 0.01 to 5 wt .-% and in particular 0.05 to 2.5 wt .-% contains. Use of plant extracts in PEG-free hair cleaners to improve suppleness and wet combability keratinic fibers. Use of pomegranate extract in hair cleansers. Use according to claim 15 for improving the Fullness and / or volume and / or combability, especially wet combability.